Caricamento...
A novel small inhibitor, LLL12, targets STAT3 in non-small cell lung cancer in vitro and in vivo
Lung cancer is the leading cause of cancer-associated mortality worldwide. Despite the development of novel molecular therapies, the prognosis for patients with locally advanced or metastatic lung cancer remains poor. Therefore, the identification of novel therapeutic approaches is required. In nume...
Salvato in:
| Pubblicato in: | Oncol Lett |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144917/ https://ncbi.nlm.nih.gov/pubmed/30250605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9262 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|